Prognostic value of platelet to lymphocyte ratio in patients with non-small cell lung cancer
Egyptian Journal of Hospital Medicine [The]. 2018; 72 (9): 5298-5303
en Inglés
| IMEMR
| ID: emr-199992
ABSTRACT
Background:
The prognostic value of Platelet-to-lymphocyte ratio [PLR] in patients with non-small-cell lung cancer [NSCLC] is still indistinct. We conducted this study to assess the prognostic significance of pretreatment PLR in patients with unresectable NSCLC
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Idioma:
Inglés
Revista:
Egypt. J. Hosp. Med.
Año:
2018
Similares
MEDLINE
...
LILACS
LIS